THE ROLE OF ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND ANTI-CYCLIC CITRULLINATED PEPTIDE IN RHEUMATOID ARTHRITIS EGYPTIAN PATIENTS

Anti-Carbamylated antibodies as a marker of activity and disability in Rheumatoid Arthritis

COVID-19 VACCINE IN EGYPTIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND OTHER RHEUMATIC DISEASES

Anti-Carbamylated antibodies as a marker of activity and disability in Rheumatoid Arthritis

COVID-19 among Rheumatoid Arthritis Patients on ‎Immunosuppressive Therapy During the First Wave of the COVID-‎‎19 Pandemic: a Prospective Comparative Study ‎

Role of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients during COVID-19 Pandemic

Anti-cyclic citrullinated peptide antibodies in thediagnosis of rheumatoid arthritis:Correlation with some clinical and laboratory data

Obesity among Rheumatoid Arthritis Patients and its Relation to Disease Activity: Cross-sectional Study among the Egyptian Population

Q192R PARAOXONASE 1 GENE POLYMORPHISM AMONG RHEUMATOID ARTHRITIS PATIENTS IN ZAGAZIG UNIVERSITY HOSPITALS

A Study of The Association Between Cysteinyl Aspartate Protease -5 (CASP5) Gene Expression & Plasma Level and The Risk of Rheumatoid Arthritis (RA)